Nasdaq denies grace period for KALA BIO (NASDAQ: KALA) after 1-for-50 split
Rhea-AI Filing Summary
KALA BIO, Inc. (KALA) disclosed that on August 27, 2026 it received a Staff Determination Letter from Nasdaq stating that its common stock has failed to meet the $1.00 minimum closing bid price requirement for The Nasdaq Capital Market for 30 consecutive business days from July 16 through August 26, 2026. Under normal circumstances, this would trigger a 180-day grace period, but Nasdaq determined KALA is not eligible for any compliance period because it effected a 1-for-50 reverse stock split on May 11, 2026 within the prior year. KALA plans to timely request a hearing before the Nasdaq Hearings Panel, which will stay any suspension or delisting action while the Panel considers the matter. The company states there is no assurance that continued listing will be granted or that it will regain and maintain compliance with the Minimum Bid Price Requirement or other Nasdaq listing standards.
Positive
- None.
Negative
- Nasdaq delisting risk with no automatic cure period: KALA BIO’s stock traded below $1.00 for 30 consecutive business days, and because it completed a 1-for-50 reverse stock split on May 11, 2026, Nasdaq did not grant the usual 180-day compliance period, increasing near-term listing uncertainty.
8-K Event Classification
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
1 item
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Key Figures
Minimum Bid Price Requirement: $1.00 per share
Non-compliance period: 30 consecutive business days
Reverse stock split ratio: 1-for-50
+3 more
6 metrics
Minimum Bid Price Requirement
$1.00 per share
Nasdaq Listing Rule 5550(a)(2) minimum closing bid price for continued listing
Non-compliance period
30 consecutive business days
Closing bid below $1.00 from July 16, 2026 through August 26, 2026
Reverse stock split ratio
1-for-50
Reverse split of common stock effected on May 11, 2026
Typical compliance period
180 calendar days
Standard grace period under Nasdaq Listing Rule 5810(c)(3)(A) not granted here
Non-compliance period start date
July 16, 2026
First of 30 consecutive business days with bid price below $1.00
Staff Determination Letter date
August 27, 2026
Date Nasdaq notified KALA of non-compliance and ineligibility for compliance period
Key Terms
Minimum Bid Price Requirement, Nasdaq Listing Rule 5550(a)(2), Nasdaq Listing Rule 5810(c)(3)(A)(iv), reverse stock split, +2 more
6 terms
Minimum Bid Price Requirement market
"the Company is not in compliance with the minimum bid price requirement"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Listing Rule 5550(a)(2) regulatory
"set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”)"
Nasdaq Listing Rule 5810(c)(3)(A)(iv) regulatory
"pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iv), the Staff has determined"
reverse stock split financial
"because the Company has effected a reverse stock split in the prior one-year period"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Nasdaq Hearings Panel regulatory
"request a hearing before the Nasdaq Hearings Panel (the “Panel”)"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
forward-looking statements regulatory
"contains “forward-looking statements” within the meaning of the Private Securities"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
FAQ
What Nasdaq notice did KALA (KALA) receive about its listing?
KALA received a Nasdaq Staff Determination Letter on August 27, 2026 stating its common stock failed the $1.00 minimum bid requirement after trading below that level for 30 consecutive business days from July 16–August 26, 2026.
Why didn’t KALA (KALA) get a 180-day grace period from Nasdaq?
Nasdaq cited Listing Rule 5810(c)(3)(A)(iv), determining KALA is ineligible for a 180-day compliance period because it effected a 1-for-50 reverse stock split of its common stock on May 11, 2026 within the prior one-year period.
What minimum bid price requirement is KALA (KALA) currently not meeting?
KALA is not in compliance with the Nasdaq Capital Market’s Minimum Bid Price Requirement in Listing Rule 5550(a)(2), which requires a minimum $1.00 per share closing bid price for its common stock.
How does KALA (KALA) plan to respond to Nasdaq’s determination?
KALA intends to timely request a hearing before the Nasdaq Hearings Panel under the Nasdaq Listing Rule 5800 Series. A timely hearing request will stay any suspension or delisting action while the Panel reviews the case.
Is there any assurance KALA (KALA) will remain listed on Nasdaq?
No. KALA states there can be no assurance that its request for continued listing will be granted, or that it will be able to regain and maintain compliance with the Minimum Bid Price Requirement and other Nasdaq continued listing requirements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
